Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | ACP3 | P15309 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7704413 | 1.00 | KMT2A (0.42) | KMT2ATHRBCYP3A4EPHX1ACP3 | |
| SCHEMBL7306869 | 1.00 | KMT2A (0.42) | KMT2ATHRBCYP3A4EPHX1ACP3 | |
| SCHEMBL10581191 | 0.80 | KMT2A (0.41) | KMT2ATHRBCYP3A4EPHX1ACP3 | |
| SCHEMBL7442974 | 0.78 | MIF (0.35) | KMT2ATHRBCYP3A4ALDH1A1LMNA | |
| SCHEMBL2796305 | 0.78 | AOC3 (0.41) | KMT2AALDH1A1GAALMNA | |
| SCHEMBL198465 | 0.77 | TSHR (0.46) | KMT2ATHRBCYP3A4EPHX1TSHR | |
| SCHEMBL8692714 | 0.77 | THRB (0.40) | KMT2ATHRBCYP3A4EPHX1TSHR | |
| SCHEMBL198464 | 0.77 | TSHR (0.46) | KMT2ATHRBCYP3A4EPHX1TSHR | |
| SCHEMBL27625768 | 0.77 | TSHR (0.46) | KMT2ATHRBCYP3A4EPHX1TSHR | |
| SCHEMBL11176872 | 0.77 | CYP2D6 (0.34) | KMT2ATSHRLMNACYP2D6SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 555 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4347572-A1 | AMINO ACIDS BEARING A TETRAZINE MOIETY | VALANX Biotech GmbH (AT) | 2024-04-10 | — | — | EP | claimed |
| EP-4259633-A1 | PROCESSES FOR THE PREPARATION OF ZANUBRUTINIB AND INTERMEDIATES THEREOF | Teva Pharmaceuticals International GmbH (CH) | 2023-10-18 | — | — | EP | claimed |
| EP-4217367-A1 | LIQUID COMPOSITION COMPRISING PEPTIDE ALDEHYDE | BASF SE (DE) | 2023-08-02 | — | — | EP | claimed |
| WO-2023079128-A1 | CATALYTIC HYDROGENATION OF AROMATIC NITRO COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-05-11 | — | — | WO | claimed |
| EP-4171578-A1 | PROCESS FOR SYNTHESIZING CATIONIC LIPIDS | Bristol-Myers Squibb Company (US) | 2023-05-03 | — | — | EP | claimed |
| EP-4139305-A1 | HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF | iOmx Therapeutics AG (DE) | 2023-03-01 | — | — | EP | claimed |
| WO-2022125862-A1 | PROCESSES FOR THE PREPARATION OF ZANUBRUTINIB AND INTERMEDIATES THEREOF | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2022-06-16 | — | — | WO | claimed |
| WO-2021262745-A1 | PROCESS FOR SYNTHESIZING CATIONIC LIPIDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-12-30 | — | — | WO | claimed |
| WO-2021216722-A1 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2021-10-28 | — | — | WO | claimed |
| WO-2021214117-A1 | HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF | IOMX THERAPEUTICS AG (DE) | 2021-10-28 | — | — | WO | claimed |
| WO-1999067221-A1 | COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS | ELAN PHARMACEUTICALS, INC. (US) | 1999-12-29 | — | — | WO | claimed |
| WO-1999058545-A1 | PROCESS FOR PREPARATION OF 4,5-EPOXYMORPHINAN-6-OXYGLUCURONIDES | CENES LIMITED (GB) | 1999-11-18 | — | — | WO | claimed |
| EP-0768303-A1 | OPTICALLY ACTIVE QUINOLINECARBOXYLIC ACID DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1997-04-16 | — | — | EP | claimed |
| EP-0469887-B1 | Acetamide derivatives | ZENECA LTD (GB) | 1994-12-14 | — | — | EP | claimed |
| US-5270342-A | Acetamide derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-12-14 | — | — | US | claimed |
| CN-1049451-A | Antibiotic composite | SANRAKU INC (JP) | 1991-02-27 | — | — | CN | claimed |
| EP-0400610-A1 | 5-Fluorouracil derivatives | UBE INDUSTRIES, LTD. (JP) | 1990-12-05 | — | — | EP | claimed |
| EP-0113330-B1 | ACYLATED ENAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THESE COMPOUNDS | BIOTEC (Société Anonyme) (BE) | 1989-03-01 | — | — | EP | claimed |
| US-4269773-A | CEPHALOSPORINS | SHIONOGI & CO., LTD. (JP) | 1981-05-26 | — | — | US | claimed |
| US-4103086-A | 8-Oxo-4-thia-1-azabicyclo (4.2.0)-oct-2-ene derivatives | SMITHKLINE CORPORATION (US) | 1978-07-25 | — | — | US | claimed |